OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Marine natural products with monoamine oxidase (MAO) inhibitory activity
Ahreum Hong, Le Cam Tu, Inho Yang, et al.
Pharmaceutical Biology (2020) Vol. 58, Iss. 1, pp. 716-720
Open Access | Times Cited: 13

Showing 13 citing articles:

Marine natural products
Anthony R. Carroll, Brent R. Copp, Rohan A. Davis, et al.
Natural Product Reports (2022) Vol. 39, Iss. 6, pp. 1122-1171
Closed Access | Times Cited: 212

Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma
Narayan D. Chaurasiya, Francisco León, Ilias Muhammad, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4297-4297
Open Access | Times Cited: 44

Promising botanical-derived monoamine oxidase (MAO) inhibitors: pharmacological aspects and structure-activity studies
Tuyelee Das, Suchismita Chatterjee Saha, Sunita Kumari, et al.
South African Journal of Botany (2021) Vol. 146, pp. 127-145
Open Access | Times Cited: 42

A review of monoamine oxidase (MAO) inhibitors in tobacco or tobacco smoke
Sa Weon Hong, Paul Teesdale‐Spittle, Rachel Page, et al.
NeuroToxicology (2022) Vol. 93, pp. 163-172
Closed Access | Times Cited: 19

Microorganism-Derived Molecules as Enzyme Inhibitors to Target Alzheimer’s Diseases Pathways
Thi Hanh Nguyen, San‐Lang Wang, Van Bon Nguyen
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 580-580
Open Access | Times Cited: 8

The Emerging Role of Marine Natural Products for the Treatment of Parkinson’s Disease
N.P. Deepika, Md. Habibur Rahman, Sandhya Chipurupalli, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 22, Iss. 6, pp. 801-816
Closed Access | Times Cited: 9

Recent Report on Indoles as a Privileged anti-viral Scaffold in Drug Discovery
Asmita Singh, Charu Bhutani, Pankaj Khanna, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117017-117017
Closed Access | Times Cited: 1

Chromenone Derivatives as Monoamine Oxidase Inhibitors from Marine-Derived MAR4 Clade Streptomyces sp. CNQ-031
Jong‐Min Oh, Chaeyoung Lee, Sang‐Jip Nam, et al.
Journal of Microbiology and Biotechnology (2021) Vol. 31, Iss. 7, pp. 1022-1027
Open Access | Times Cited: 9

An Overview of Aplysinopsins: Synthesis and Biological Activities
Eslam R. El‐Sawy, Gilbert Kirsch
Marine Drugs (2023) Vol. 21, Iss. 5, pp. 268-268
Open Access | Times Cited: 3

Synthetic Analogs of Marine Alkaloid Aplysinopsin Suppress Anti-Apoptotic Protein BCL2 in Prostate Cancer
Eslam R. El‐Sawy, Zeinab A. Elshahid, Ahmed A. F. Soliman, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 109-109
Open Access | Times Cited: 5

Pannorin isolated from marine Penicillium sp. SG-W3: a selective monoamine oxidase A inhibitor
Jong‐Min Oh, Qian Gao, Woong‐Hee Shin, et al.
Applied Biological Chemistry (2024) Vol. 67, Iss. 1
Open Access

Page 1

Scroll to top